Paul Calabresi Career Development Award for Clinical Oncology (K12)
The summary for the Paul Calabresi Career Development Award for Clinical Oncology (K12) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Paul Calabresi Career Development Award for Clinical Oncology (K12): Purpose: This funding opportunity announcement (FOA) issued by the National Cancer Institute (NCI) encourages applications for institutional research career development (K12) programs from applicant organizations that propose to promote the training and career development of translational and clinical trials researchers. The purpose of the Paul Calabresi Career Development Award in Clinical Oncology (PCACO) K12 (NIH Institutional Research Career Development K12 grant mechanism) is to increase the number of clinicians (M.D.s, D.O.s, Pharm.D.s) and basic research scientists (Ph.D.s. or equivalents) who are trained to design and administer hypothesis-based pilot/Phase I, Phase II, and Phase III cancer therapeutic clinical trials in team research settings. A PCACO can support the research career development of clinicians only (single-track program) or clinicians and Ph.D. basic research scientists (dual-track program). Clinical and basic research scientists will collaborate and interact to expedite the translation of basic science research discoveries into patient-oriented therapeutic cancer research. The PCACO is not intended to train laboratory-based scientists whose research will be primarily focused upon the use of animal or other model systems. Mechanism of Support: This FOA will use the NIH Institutional Research Career Development K12 grant mechanism. K12 programs may not be transferred from one institution to another (See section VI.2). Funds Available and Anticipated Number of Awards: The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. Awards are renewable.
|Federal Grant Title:||Paul Calabresi Career Development Award for Clinical Oncology (K12)|
|Federal Agency Name:||National Institutes of Health|
|Grant Categories:||Education Health|
|Type of Opportunity:||Discretionary|
|Funding Opportunity Number:||PAR-10-155|
|Type of Funding:||Grant|
|CFDA Descriptions:||Cancer Treatment Research|
|Current Application Deadline:||Jun 11, 2012|
|Original Application Deadline:||Jul 10, 2013|
|Posted Date:||Mar 26, 2010|
|Creation Date:||Mar 26, 2010|
|Archive Date:||Jul 11, 2012|
|Total Program Funding:|
|Maximum Federal Grant Award:|
|Minimum Federal Grant Award:|
|Expected Number of Awards:|
|Cost Sharing or Matching:||No|
- Applicants Eligible for this Grant
- Public and State controlled institutions of higher education - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER Webmaster FBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
- Similar Government Grants
- • Resource Center for the Consortium for Pancreatic Ductal Adenocarcinoma (PDAC) Translation...
- • Consortium for Pancreatic Ductal Adenocarcinoma (PDAC) Translational Studies on the Tumor ...
- • Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery (R01)
- • Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery (R21)
- • Limited Competition: Cancer Immunotherapy Trials Network (CITN)(UM1)
- • Breast and Prostate Cancer Data Quality and Patterns of Care Study
- • Consortium Therapeutic Studies of Primary Central Nervous System Malignancies in Adults
- • National Cooperative Drug Discovery Groups for Cancer
- More Grants from the National Institutes of Health
- • Limited Competition for NIH-Industry Program: Discovering Pediatric New Therapeutic Uses f...
- • Environmental influences on Placental Origins of Development (ePOD) (R01)
- • Limited Competition for NIH-Industry Program: Discovering New Therapeutic Uses for Existin...
- • Pre-application for the NIH-Industry Program: Discovering New Therapeutic Uses for Existin...
- • Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R01)